Multivitamins before pregnancy may prevent prematurity

- Last updated on GMT

Related tags: Childbirth

Women who take multivitamins before becoming pregnant are less
likely to give birth to premature babies, suggests a new study.

It found that women who took multivitamins before conceiving were half as likely to deliver their babies before 37 weeks of pregnancy.

However, continuing the multivitamins through the first months of pregnancy appeared to have no influence on the risk of prematurity, write the researchers in the 1 November issue of the American Journal of Epidemiology​(160(9):886-92).

Previous research suggests that multivitamin use before and during pregnancy can diminish diet-related deficiencies of certain micronutrients and potentially prevent preterm birth, note the researchers from the University of North Carolina at Chapel Hill.

To assess this association, the authors analysed data from a large study that recruited 2,010 women at 24-29 weeks of pregnancy in four different prenatal care clinics between 1995 to 2000.

While vitamin use before conception reduced the risk of premature birth, prenatal and periconceptional use showed no impact on the likelihood of preterm birth.

The researchers noted that further studies are needed with a larger sample of preconceptional users to confirm their findings.

In the UK about 8 per cent of babies are born prematurely, before 37 rather than the usual 40 weeks of gestation.

Previous research has demonstrated that folic acid, found in multivitamins, helps to prevent birth defects.

Related news

Show more

Related products

show more

20 Years Palm Tocotrienols Brain Health Research

20 Years Palm Tocotrienols Brain Health Research

ExcelVite Sdn. Bhd. | 25-Sep-2019 | Technical / White Paper

Research of Vitamin E tocotrienol in brain health and neuroprotection began twenty years ago.
Today, other health benefits have been discovered...

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 19-Sep-2019 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

Related suppliers

Follow us

Featured Events

View more


View more